Risultati per: La FDA approva il sistema di riabilitazione dell’ictus

This Perspective discusses new FDA guidance for pulse oximeters that aims to reduce disparities in device performance related to skin pigment.

Rapidità, sicurezza, efficacia. Primo ospedale pubblico a usarla

Rapidità, sicurezza, efficacia. Primo ospedale pubblico a usarla

This JAMA Insights discusses the recent FDA approval of obecabtagene autoleucel for adults with relapsed or refractory B-cell acute lymphoblastic leukemia and provides regulatory considerations.

The US Food and Drug Administration (FDA) recently approved the rapid-acting human insulin analog insulin-aspart-szjj, marketed as Merilog, as a biosimilar to insulin aspart (Novolog).

So far, studies suggest modest benefits for acute postoperative pain, but many questions remain.

Semaglutide, marketed as Ozempic, recently became the first glucagon-like peptide 1 (GLP-1) receptor agonist approved by the US Food and Drug Administration (FDA) to reduce the risk of worsening kidney disease, kidney failure, and death due to cardiovascular disease in adults with type 2 diabetes (T2D) and chronic kidney disease (CKD), a common complication of T2D.

Ampio studio sul New England, protegge il cuore anche in pillola

Ok alla rimborsabilità negli stadi iniziali della malattia, può aumentare le guarigioni

Al Don Gnocchi Firenze il Computer assisted rehabilitation lab

The US Food and Drug Administration (FDA) recently authorized the marketing of 20 ZYN nicotine pouch products, the first of their kind to receive such approval. The decision followed an extensive scientific review that concluded that the benefits of these cigarette alternatives outweighed the risks, in line with the public health standards set by the 2009 Family Smoking Prevention and Tobacco Control Act.

The respiratory syncytial virus (RSV) vaccines marketed as Abrysvo by Pfizer and Arexvy by GSK will now require a warning about the risk of Guillain-Barré syndrome (GBS), the US Food and Drug Administration (FDA) announced recently.

Prima in Italia, finanziata dal ministero della Salute

Sono previste sei giornate di screening gratuiti

Aumenta le cellule ematiche vantaggiose,migliora i globuli rossi

Invia notifiche tramite app in caso di dosi dimenticate